Humana (HUM) announced new partnerships to improve heart health for eligible Medicare Advantage members through value-based care. Building on Humana’s existing cardiac care partnership with CVAUSA’s Novocardia Care Solutions division, new agreements with Karoo Health, US Heart and Vascular and Chamber Cardio further expand the company’s comprehensive cardiac care program. “Managing a heart condition can feel overwhelming. Our members need integrated, coordinated, evidence-based care that meets them where they are,” said Caraline Coats, Senior Vice President Clinical Strategy at Humana. “As a leader in value-based care, Humana is committed to expanding access to high-quality, whole-person care that supports better health outcomes.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HUM:
- Humana Reaffirms 2026 Earnings Guidance in Investor Meetings
- Humana price target lowered to $176 from $245 at Barclays
- Humana: Uncertain Margin Recovery and Star Rating Headwinds Drive Neutral ‘Hold’ Stance
- Humana price target lowered to $206 from $290 at Wells Fargo
- Humana price target lowered to $200 from $285 at Truist
